Showing results (81-90 of 148) with videos related to
Sort By:
Pageof 15
Atherosclerosis|July 5, 2018
Performance of LDL-C calculated with Martin's formula compared to the Friedewald equation in familial combined hyperlipidemiaRoopa Mehta, Enrique Reyes-Rodríguez, Omar Yaxmehen Bello-Chavolla, et al.Journal of Diabetes|February 12, 2026
Delphi Consensus on the Use of Fenofibrate as Systemic Therapy for the Prevention of Diabetic Retinopathy ProgressionRichard C O'Brien, Khalifa Abdallah, Xuehong Dong, et al.American Heart Journal|July 31, 2013
Results of a reevaluation of cardiovascular outcomes in the RECORD trialKenneth W Mahaffey, Gail Hafley, Sheila Dickerson, et al.Diabetes Care|October 27, 2006
Design and validation of a population-based definition of the metabolic syndromeCarlos A Aguilar-Salinas, Rosalba Rojas, Clicerio Gonzalez-Villalpando, et al.The International Journal of Biological Markers|April 13, 2024
A systematic review of biobanks in Latin America: Strengths and limitations for biomedical researchJ Adrián Rivera-Alcántara, Natalia Esparza-Hurtado, Gabriela A Galán-Ramírez, et al.Diabetes Care|January 29, 2011
Insulin degludec in type 1 diabetes: a randomized controlled trial of a new-generation ultra-long-acting insulin compared with insulin glargineKåre I Birkeland, Philip D Home, Ulrich Wendisch, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|August 31, 2014
Determinants of VLDL composition and apo B-containing particles in familial combined hyperlipidemiaIvette Cruz-Bautista, Roopa Mehta, Javier Cabiedes, et al.Current Diabetes Reviews|January 29, 2008
The ATP-binding cassette transporter subfamily A member 1 (ABC-A1) and type 2 diabetes: an association beyond HDL cholesterolCarlos A Aguilar Salinas, Ivette Cruz-Bautista, Roopa Mehta, et al.Diabetes, Obesity & Metabolism|May 16, 2018
Efficacy and safety of MK-1293 insulin glargine compared with originator insulin glargine (Lantus) in type 2 diabetes: A randomized, open-label clinical trialPriscilla A Hollander, Wendy L Carofano, Raymond L H Lam, et al.Diabetes Care|May 13, 2011
Incidence and prevalence of unrecognized myocardial infarction in people with diabetes: a substudy of the Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycemia in Diabetes (RECORD) studyMichael R MacDonald, Mark C Petrie, Philip D Home, et al.Pageof 15